WallStreetZenWallStreetZen

NASDAQ: ADPT
Adaptive Biotechnologies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Adaptive Biotechnologies revenue was $252.75M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $94.0M, up 59.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ADPT annual revenue was $179.0M, with 5.1% growth year-over-year.

ADPT past revenue growth

How has ADPT's revenue growth performed historically?

Company
42.57%
Industry
258.54%
Market
21.98%
ADPT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ADPT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ADPT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ADPT revenue history

Current Revenue
$252.8M
Current Earnings
-$79.6M
Current Profit Margin
-31.5%

Be the first to know when ADPT announces revenue.

ADPT Revenue History By Year

ADPT Yearly RevenueADPT RevenueADPT ChangeADPT Revenue Growth
2024-12-31$178.96M$8.68M+5.10%
2023-12-31$170.28M-$15.03M-8.11%
2022-12-31$185.31M$30.96M+20.06%
2021-12-31$154.34M$55.96M+56.88%
2020-12-31$98.38M$13.31M+15.65%
2019-12-31$85.07M$29.41M+52.83%
2018-12-31$55.66M$17.22M+44.77%
2017-12-31$38.45MN/AN/A

1 of 1

Adaptive Biotechnologies Revenue FAQ

What was ADPT's revenue last quarter?

On Invalid Date, Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 2025 revenue of $93.97 million up 102.38% year over year. In the same quarter last year, Adaptive Biotechnologies's revenue was $46.44 million.

What was Adaptive Biotechnologies's revenue in 2024?

Adaptive Biotechnologies's annual revenue for the twelve months ending Dec 31, 2024 was $178.96 million, a 5.1% increase year over year.

How much does Adaptive Biotechnologies make in a day?

Based on Adaptive Biotechnologies annual revenue for the past five years, ADPT makes an average of $431,379.18 per day.

What was Adaptive Biotechnologies's annual revenue growth in the past year?

As of Q4 2025, Adaptive Biotechnologies's revenue has grown 42.57% year over year. This is 215.97 percentage points lower than the US Biotechnology industry revenue growth rate of 258.54%. Adaptive Biotechnologies's revenue in the past year totaled $252.75 million.

How much does Adaptive Biotechnologies make in a year?

Adaptive Biotechnologies's revenue by year for the past five years is:
  • Adaptive Biotechnologies's revenue for the twelve months ending Dec 31, 2024 was $178.96 million, a 5.1% increase year over year.
  • Adaptive Biotechnologies's annual revenue for Dec 31, 2023 was $170.28 million, a 8.11% decrease from 2022.
  • Adaptive Biotechnologies's annual revenue for 2022 was $185.31 million, a 20.06% increase from 2021.
  • Adaptive Biotechnologies's annual revenue for 2021 was $154.34 million, a 56.88% increase from 2020.
  • Adaptive Biotechnologies's annual revenue for 2020 was $98.38 million, a 15.65% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.